- Functional mushrooms seeing rise in popularity due to health benefits, alternative medicine options
- Predictions show global medicinal mushroom market growing annually by $13.88 billion
- Pure Extracts is ideally positioned to enter the space as experienced producer
Used for centuries for their impressive medicinal properties and health benefits, functional mushrooms are enjoying a rise in popularity, due at least in part to increased research and study of the natural fungi as well as trends toward alternative natural health options. Pure Extract Technologies, a private, plant-based extraction company with a new vertical in functional mushrooms, is focused on becoming the dominant extraction company in the industry and a leader in the rapid development and commercialization of functional mushroom products.
In an article titled “Here’s What You Need to Know About Functional Mushroom,” Stephanie Ferrari, a Massachusetts-based registered dietitian, says that there is deep scientific literature that points to the healing properties of mushrooms, specifically their immune system and cancer-prevention benefits (http://ibn.fm/3EczB). “Research suggests that mushrooms not only strengthen our immune systems but may also be useful in treating certain diseases like asthma, allergies and arthritis due to their anti-inflammatory properties,” she says.
Beyond that, the article notes that “mushrooms are low in calories, high in protein, and good sources of B vitamins, minerals and fiber. . . . Several are considered adaptogens, which means they help us to cope with stress.”
In addition, research published in “Integrative Medicine: A Clinician’s Journal,” notes that, for certain types of mushrooms, “an abundance of in vitro evidence exists that elucidates the anticancer immunological mechanisms. Preliminary research in humans is also available and is promising for treatment” (http://ibn.fm/SGEgE).
The functional mushroom industry is among the fastest growing in North America, with forecasts predicting the global medicinal mushroom market will grow annually by $13.88 billion (http://ibn.fm/mwcrf). As the industry transitions from dry biomass to extracts, many companies are unprepared for this new opportunity.
Pure Extracts, on the other hand, is ideally positioned to enter the space as an experienced producer. With a team of qualified experts and cutting-edge extraction technology, the company is set up for long-term strategic distribution and product innovation. Located in Pemberton, British Columbia, the company’s facility is built for EU-GMP certification, which allows for international sales and ensures the production of high-quality, high-purity formulations on a commercial scale.
Further establishing its power in the market, Pure Extracts has signed nondisclosure agreements to explore joint-development endeavors for product launches slated for potential Q4 delivery. The company also inked an advisory agreement with Dr. Alexander MacGregor, founder of Transpharm Canada Inc., the parent company of Toronto Institute of Pharmaceutical Technology, whose facility is a fully compliant Health Canada-licensed, Good Manufacturing Practice manufacturing and testing facility and is a full-service, clinical-development business that provides clinical trial services to biotechnology companies.
For more information, visit the company’s website at www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.psychedelicnewswire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com
PsychedelicNewsWire is part of the InvestorBrandNetwork.
